These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 30929200)
1. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma. Albano D; Bosio G; Bianchetti N; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F Ann Nucl Med; 2019 Jul; 33(7):449-458. PubMed ID: 30929200 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma. Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438 [TBL] [Abstract][Full Text] [Related]
3. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma. Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role of baseline Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563 [TBL] [Abstract][Full Text] [Related]
8. Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma. Albano D; Re A; Tucci A; Giubbini R; Bertagna F Ann Nucl Med; 2019 Apr; 33(4):280-287. PubMed ID: 30788775 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Albano D; Camoni L; Giubbini R; Bertagna F Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e897-e904. PubMed ID: 32703751 [TBL] [Abstract][Full Text] [Related]
10. Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist. Albano D; Bosio G; Tomasini D; Bonù M; Giubbini R; Bertagna F Asia Pac J Clin Oncol; 2020 Oct; 16(5):e207-e215. PubMed ID: 32762133 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY; Guo Z; Sun J; Yang WP; Li TR Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362 [No Abstract] [Full Text] [Related]
12. Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [ Sachpekidis C; Enqvist O; Ulén J; Kopp-Schneider A; Pan L; Mai EK; Hajiyianni M; Merz M; Raab MS; Jauch A; Goldschmidt H; Edenbrandt L; Dimitrakopoulou-Strauss A Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2293-2307. PubMed ID: 38456971 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma]. Wu LL; Liang JH; Wang L; Xu W; Ding CY Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850 [No Abstract] [Full Text] [Related]
16. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy. Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011 [TBL] [Abstract][Full Text] [Related]
17. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma. Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma. Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]